These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2894164)

  • 21. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
    Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
    Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects.
    Finta E; Laude D; Alföldi S; Farsang C; Elghozi JL
    J Hypertens; 2006 Aug; 24(8):1619-25. PubMed ID: 16877965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
    De Luca N; Izzo R; Fontana D; Iovino G; Argenziano L; Vecchione C; Trimarco B
    J Hypertens; 2000 Oct; 18(10):1515-22. PubMed ID: 11057441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M; Février B; Beucler I; Dairou F
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term control of blood pressure by rilmenidine in high-risk populations.
    Pillion G; Fevrier B; Codis P; Schutz D
    Am J Cardiol; 1994 Dec; 74(13):58A-65A. PubMed ID: 7998587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular variability after rilmenidine challenge: assessment of acute dosing effects by means of spectral analysis.
    Girard A; Février B; Elghozi JL
    Fundam Clin Pharmacol; 1995; 9(4):366-71. PubMed ID: 8566936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
    Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
    Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.
    Kawecka-Jaszcz K; Czarnecka D; Klocek M; Zabojszcz M; Kucharska M; Jaworski R; Pachocki R
    Blood Press; 2006; 15(1):51-8. PubMed ID: 16492616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmaco-epidemiologic evaluation of rilmenidine in 18,235 hypertensive patients].
    Luccioni R
    Presse Med; 1995 Dec; 24(38):1857-64. PubMed ID: 8545441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.